You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

List of Excipients in API lansoprazole


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing lansoprazole

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC PREVACID lansoprazole 0067-6286 D&C RED NO. 28
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC PREVACID lansoprazole 0067-6286 FD&C BLUE NO. 1
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC PREVACID lansoprazole 0067-6286 FD&C GREEN NO. 3
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC PREVACID lansoprazole 0067-6286 FD&C RED NO. 40
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC PREVACID lansoprazole 0067-6286 GELATIN
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC PREVACID lansoprazole 0067-6286 HYDROXYPROPYL CELLULOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing lansoprazole

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008 .GAMMA.-DECALACTONE
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008 3-HEXEN-1-OL
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008 3-HEXENYL ACETATE
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008 3-HEXENYL BUTYRATE
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008 3-HEXENYL HEXANOATE
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008 ACACIA
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for lansoprazole

Excipient focus: .GAMMA.-DECALACTONE

Excipient focus: 3-HEXEN-1-OL

Excipient focus: 3-HEXENYL ACETATE

Excipient focus: 3-HEXENYL ACETATE, CIS-

Excipient focus: 3-HEXENYL BUTYRATE

Excipient focus: 3-HEXENYL HEXANOATE

Excipient focus: ACACIA

Excipient focus: ACETONE

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM CHLOROHYDREX PROPYLENE GLYCOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ASCORBIC ACID

Excipient focus: ASPARTAME

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARNAUBA WAX

Excipient focus: CARRAGEENAN

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETYL ALCOHOL

Excipient focus: CI 77492

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DEXTROSE

Excipient focus: ETHYL 2-METHYLBUTYRATE

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION

lansoprazole drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER DISPERSION

Company Ingredient NDC
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC lansoprazole 0067-6286
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008
Teva Pharmaceuticals USA Inc lansoprazole 0093-7350
L Perrigo Company lansoprazole 0113-0116
L Perrigo Company lansoprazole 0113-0117
L Perrigo Company lansoprazole 0113-1114
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: ETHYL BUTYRATE

Excipient focus: ETHYL ISOVALERATE

Excipient focus: ETHYL VALERATE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERYL 1-OLEATE

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HEXYL HEXANOATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM CARBONATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTITOL

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: MEGLUMINE

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

lansoprazole drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC lansoprazole 0067-6286
Teva Pharmaceuticals USA Inc lansoprazole 0093-3008
Teva Pharmaceuticals USA Inc lansoprazole 0093-7350
L Perrigo Company lansoprazole 0113-0116
L Perrigo Company lansoprazole 0113-0117
L Perrigo Company lansoprazole 0113-1114
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER

Excipient focus: METHYL CINNAMATE

Excipient focus: N-BUTYL ALCOHOL

Excipient focus: NONOXYNOL-100

Excipient focus: PHENYLALANINE

Excipient focus: POLYACRYLIC ACID

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 20

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM CHLORIDE

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: RAW SUGAR

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITOL

Excipient focus: STARCH, CORN

Excipient focus: STRAWBERRY

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: SUGARCANE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links